Supply Chain | 28 August 2026
DKSH to acquire Thai API distributor P.R. Chemicals
Under the agreement, DKSH will acquire 100% of P.R. Chemicals and integrate the business into its existing operations
Under the agreement, DKSH will acquire 100% of P.R. Chemicals and integrate the business into its existing operations
Company’s EBITDA increased 15.2% YoY to Rs. 261.2 crore, marking the company's 15th consecutive quarter of double-digit EBITDA growth
Brenntag will market the co-branded high-purity phosphates globally in pack sizes of 15 kg or less
BYPHAR brings together Brenntag’s distribution network, regulatory expertise and technical services into a single structured offering
Aims to tighten temperature control in pharma logistics
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
The company posted revenue of €1,267 million, up 6% on a constant currency basis
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
The company allocated €56 million to research and development for next-generation line solutions
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
Subscribe To Our Newsletter & Stay Updated
